According to Enochian Biosciences's latest financial reports the company's current earnings (TTM) are -$0.11 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$38.39 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.11 B | -1.72% |
2022 | -$0.11 B | 182.88% |
2021 | -$38.39 M | 246.9% |
2020 | -$11.07 M | 213.91% |
2019 | -$3.53 M | -87.52% |
2018 | -$28.25 M | 1311.54% |
2017 | -$2.01 M | -29.21% |
2016 | -$2.83 M | |
2014 | -$2.57 M | 6701.79% |
2013 | -$0.04 M | 16.61% |
2012 | -$0.04 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 3.80% | ๐บ๐ธ USA |